Page History
...
Section | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ISA-TAB-Nano Introduction
...
The ISA-TAB-Nano specification is intended to facilitate the submission and exchange of nanomaterial descriptions and characterization data (metadata and summary data) along with the other files (raw/derived data files, image files, protocol documents, etc.) among individual researchers and to/from nanotechnology resources like the NCI’s cancer Nanotechnology Laboratory (caNanoLab) portal [https://cananolab.nci.nih.gov/caNanoLab] caNanoLab) portal and the Nanomaterial-Biological Interactions (NBI) knowledgebase [http://nbi.oregonstate.edu/].
Multiexcerpt include | ||||||
---|---|---|---|---|---|---|
|
...
The ISA-TAB-Nano project is an effort of the National Cancer Institute (NCI) National Cancer Informatics Program (NCIP) Nanotechnology Informatics Working Group (Nano WG).
ISA-TAB-Nano Standards Re-Use
...
The ISA-TAB-Nano format specification is based on an existing specification developed by the ISA-commmunity (http://www.isa-tools.org)
Multiexcerpt include | ||||||
---|---|---|---|---|---|---|
|
Multiexcerpt include | ||||||
---|---|---|---|---|---|---|
|
...
Like ISA-TAB, ISA-TAB-Nano provides fields for entering and referencing terms selected from ontologies and standard terminologies. The ontologies are available at BioPortal (http://www.bioontology.org)
Multiexcerpt include | ||||||
---|---|---|---|---|---|---|
|
NanoParticle Ontology (NPO) [http://www.nano-ontology.org]
Multiexcerpt include | ||||||
---|---|---|---|---|---|---|
|
...
The Table below represents extensions made to each ISA-TAB file in support of ISA-TAB-Nano.
ISA-TAB Extension Field Name | ISA-TAB File | Purpose | |||
---|---|---|---|---|---|
Investigation Disease | Investigation | To capture and retrieve investigations associated with specific disease modalities such as cancer | |||
Investigation Disease Term Accession Number | Investigation | To enable semantic interoperability for disease terms | |||
Investigation Disease Term Source REF | Investigation | To enable semantic interoperability for disease terms | |||
Investigation Disease Term Source REF | Investigation | To enable semantic interoperability for disease terms | |||
terms | |||||
Investigation Outcome | Investigation | To enable researchers to review the outcomes of investigations for assessing the utility of the investigation in achieving scientific endpoints | |||
MATERIAL | Investigation | To allow for the identification of materials used in the investigation and associated studies | |||
Material File Name | Investigation | To identify the name of the Material File, which lists information about the composition and characteristics of the nanomaterials or other small molecules | |||
Material Source Name | Investigation | To identify the name of the nanomaterial or small molecule associated with the Material File | Investigation Outcome | Investigation | To enable researchers to review the outcomes of investigations for assessing the utility of the investigation in achieving scientific endpoints |
Study Disease | Investigation | To capture and retrieve studies associated with specific disease modalities such as cancer | |||
Study Disease Term Accession Number | Investigation | To enable semantic interoperability for disease terms | |||
Study Disease Term Source REF | Investigation | To enable semantic interoperability for disease terms | |||
Study Outcome | Investigation | To enable researchers to review the outcomes of studies for assessing the utility of the investigation in achieving scientific endpoints | |||
Study Factor Name Term Accession Number | Investigation | To enable semantic interoperability for study factor name | |||
Study Factor Name Term Source REF | Investigation | To enable semantic interoperability for study factor namesresearchers to review the outcomes of studies for assessing the utility of the investigation in achieving scientific endpoints | |||
Study Assay Measurement Name | Investigation | To capture the variables measured in an assay to support cross study analysis | |||
Study Assay Measurement Name Term Accession Number | Investigation | To enable semantic interoperability for assay measurement names | |||
Study Assay Measurement Name Term Source REF | Investigation | To enable semantic interoperability for assay measurement names | |||
Material Source Name REF | Study | To provide a reference for the material associated with the study and identfied in the Material file | |||
Material File | Study | To provide a reference for the ISA-TAB-Nano material file that describes the material samples of a studysemantic interoperability for assay measurement names | |||
Measurement Value | Assay | To record the endpoint value of an assay measurement within the assay fileStatistic | Assay | To capture the statistical measures (e.g. mean, SD) associated with a measurement or factor value | |
All Fields | Material | To describe nanomaterials and small molecules |
...
Once the ISA-TAB-Nano files have been created, the files can be validated and submitted into nanotechnology resources that support the ISA-TAB-Nano specification. It is anticipated that validation of the files may occur via a validation service that leverages a modified version of the ISA-TAB validator [http://isatab.sourceforge.net/tools.html . -TAB validator
Multiexcerpt include | ||||||
---|---|---|---|---|---|---|
|
It is also anticipated that nanotechnology resources like caNanoLab (https://cananolab.nci.nih.gov/caNanoLab/ ), the Nanomaterial-Biological Interactions (NBI) knowledgebase (http://nbi.oregonstate.edu/) and
Multiexcerpt include | ||||||
---|---|---|---|---|---|---|
|
...
Templates for each ISA-TAB-Nano file are provided below:
A definition Definitions of terms in each file are available in the ISA-TAB-Nano Glossary Files.
ISA-TAB-Nano Example Files
...
Investigation Title: Nanotechnology Characterization Laboratory (NCL) Dendrimer-Based MRI Contrast Agent
Investigation Description: The objective of this investigation is to characterize a PAMAM dendrimer with an associated gadolinium chelate MRI contrast agent. The nanomaterials submitted for testing at the NCL were (NCL20) G4 tris (hydroxyl) terminated PAMAM dendrimer, (NCL21) G4 pyrrolidinone terminated PAMAM dendrimer, (NCL22) G4.5 COONa terminated PAMAM dendrimer, (NCL23) G4.5 COONa terminated PAMAM dendrimer-Magnevist® complex, (NCL25) G4 tris (hydroxyl) terminated PAMAM dendrimer-Magnevist® complex, and (NCL26) G4 pyrrolidinone terminated PAMAM dendrimer-Magnevist® complex. Commercially available Magnevist® (NCL24) was used as a control. NCL studies addressed in this report can be divided into three main categories: physicochemical characterization; immunotoxicology; in vitro toxicology.
Example Files:
- Investigation File: NCL Dendrimer-Based MRI Contrast Agent
- Study Files: Size by Dynamic Light Scattering (DLS) | Cytotoxicity Study
- Material Files: NCL-20 | NCL-21 | NCL-22 | NCL-23 | NCL-24 | NCL-25 | NCL-26
- Assay Files: Size by DLS Assay | Lactate Dehydrogenase (LDH) Assay | MTT AssayReport: Dentrimer-Based MRI Image Contrast Agent
ISA-TAB-Nano Spreadsheets and Associated Documents
ISA-TAB-Nano XML Specification
...
...
Include Page | ||||
---|---|---|---|---|
|